跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Butamol - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Butamol
Approved
STANDARD
Butamol
Lumar Pharmaceutical Laboratory, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9a3cef90770a4d78
Company
Lumar Pharmaceutical Laboratory, Inc.
Type
Standard
Approval Details
Approval Id
9a3cef90770a4d78
Drug Approval Philippines Name
Butamol
Product Name
Butamol
Registration Number
DRP-1817
Brand Name
Butamol
Generic Name
Salbutamol (As Sulfate)
Dosage Form
Syrup
Dosage Strength
2mg/5mL
Manufacturer
Lumar Pharmaceutical Laboratory, Inc.
Issuance Date
27 April 2021
Expiry Date
24 May 2026
Pharmacologic Category
Selective Beta-2-Adrenoreceptor Agonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9a3cef90770a4d78
Type
Standard
Back to Philippines FDA Approvals